Evaluating the Use of Thymoglobulin, Sirolimus, and Donor Bone Marrow With Kidney Transplantation Patients
Condition: Kidney Transplantation
Intervention: Drug: Allogeneic Bone Marrow, Anti-Thymocyte Globulin (Sangstat) & Sirolimus (Wyeth-Ay
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified March 22, 2007
Intervention: Drug: Allogeneic Bone Marrow, Anti-Thymocyte Globulin (Sangstat) & Sirolimus (Wyeth-Ay
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Completed - verified March 22, 2007